Pages that link to "Q47966083"
Jump to navigation
Jump to search
The following pages link to Effect of ONO-5334 on bone mineral density and biochemical markers of bone turnover in postmenopausal osteoporosis: 2-year results from the OCEAN study. (Q47966083):
Displaying 28 items.
- From disease to treatment: from rare skeletal disorders to treatments for osteoporosis (Q26764854) (← links)
- Modulation of osteoclast differentiation and bone resorption by Rho GTPases (Q26851553) (← links)
- Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis (Q33814283) (← links)
- Extracorporeal shock waves alone or combined with raloxifene promote bone formation and suppress resorption in ovariectomized rats (Q36269757) (← links)
- Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial (Q36471074) (← links)
- Emerging drugs for osteoporosis (Q38226342) (← links)
- Imaging of site specific bone turnover in osteoporosis using positron emission tomography (Q38244363) (← links)
- Perspectives on osteoporosis therapies (Q38313739) (← links)
- Novel targets for the prevention of osteoporosis - lessons learned from studies of metabolic bone disorders (Q38470745) (← links)
- Cathepsin K Inhibition: A New Mechanism for the Treatment of Osteoporosis (Q38579689) (← links)
- Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned (Q38666521) (← links)
- Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences (Q38784335) (← links)
- Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability (Q39385131) (← links)
- High frequency of vertebral fracture and low bone quality in patients with rheumatoid arthritis-Results from TOMORROW study (Q39532345) (← links)
- Applicability of in vitro-in vivo translation of cathepsin K inhibition from animal species to human with the use of free-drug hypothesis (Q46414905) (← links)
- Site specific measurements of bone formation using [18F] sodium fluoride PET/CT. (Q52654951) (← links)
- An Ectosteric Inhibitor of Cathepsin K Inhibits Bone Resorption in Ovariectomized Mice. (Q52761114) (← links)
- Nonclinical and clinical pharmacological characterization of the potent and selective cathepsin K inhibitor MIV-711. (Q54987147) (← links)
- Effect of a cathepsin K inhibitor on arthritis and bone mineral density in ovariectomized rats with collagen-induced arthritis. (Q55506744) (← links)
- Advances in the discovery of cathepsin K inhibitors on bone resorption. (Q55645981) (← links)
- Cortical bone mineral density is increased by the cathepsin K inhibitor ONO-5334, which leads to a robust increase in bone strength: results from a 16-month study in ovariectomised cynomolgus monkeys (Q57792097) (← links)
- Developing a toolkit for the assessment and monitoring of musculoskeletal ageing (Q58293684) (← links)
- Suppression of cathepsin K biomarker in synovial fluid as a free-drug–driven process (Q60919739) (← links)
- Effects of the Cathepsin K Inhibitor ONO-5334 and Concomitant Use of ONO-5334 with Methotrexate on Collagen-Induced Arthritis in Cynomolgus Monkeys (Q64235413) (← links)
- Combination therapy with ONO-KK1-300-01, a cathepsin K inhibitor, and parathyroid hormone results in additive beneficial effect on bone mineral density in ovariectomized rats (Q86909021) (← links)
- Bone turnover markers and pharmacokinetics of a new sustained-release formulation of the cathepsin K inhibitor, ONO-5334, in healthy post-menopausal women (Q87155621) (← links)
- Associations of Serum Cathepsin K and Polymorphisms in CTSK Gene With Bone Mineral Density and Bone Metabolism Markers in Postmenopausal Chinese Women (Q89965116) (← links)
- Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing (Q97687171) (← links)